Hepatitis C incidence has been shown to be increased in chronic fatigue syndrome patients.
Prevalence[edit | edit source]
It is estimated that between 130-200 million people worldwide have a hepatitis C infection, occurring most commonly in Africa and Central and East Asia. In 2013, hepatitis C was the cause of around 358,000 deaths due to cirrhosis and 343,000 deaths due to liver cancer.
Transmission[edit | edit source]
Signs and symptoms[edit | edit source]
Diagnosis[edit | edit source]
Hepatitis C in Chronic Fatigue Syndrome[edit | edit source]
Notable studies[edit | edit source]
Potential treatments[edit | edit source]
Learn more[edit | edit source]
References[edit | edit source]
- Siu, Gavin Ka Yu; Zhou, Fan; Yu, Mei Kuen; Zhang, Leiliang; Wang, Tuanlao; Liang, Yongheng; Chen, Yangchao; Chan, Hsiao Chang; Yu, Sidney (2016), "Hepatitis C virus NS5A protein cooperates with phosphatidylinositol 4-kinase IIIα to induce mitochondrial fragmentation", Scientific Reports 6, doi:10.1038/srep23464
- "Hepatitis C Fact sheet N°164", WHO, July 2015, retrieved Feb 4, 2016
- GBD 2013 Mortality and Causes of Death, Collaborators (Dec 17, 2014), "Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013.", Lancet, 385 (9963): 117–71, doi:10.1016/S0140-6736(14)61682-2, PMC , PMID 25530442
World Health Organization (WHO) - "A specialized agency of the United Nations that is concerned with public health. It was established on 7 April 1948, and is headquartered in Geneva, Switzerland. The WHO is a member of the United Nations Development Group. Its predecessor, the Health Organization, was an agency of the League of Nations." The International Statistical Classification of Diseases and Related Health Problems (ICD) is maintained by WHO.